Replies to post #43695 on Curative Biotechnology Inc (CUBT)

[Threeflight]

Being honest, a lot of the RS plays on the NASDAQ have worked out well as of late. Very hot. They get better funding after the RS, so the dilution is much less toxic. Plus day traders like to play the stocks which have such a low OS and float on the NASDAQ (no commissions) ....that they can flip 100 times a day.....which CUBT would have after a RS uplist to a higher exchange. I have traded 6 different stocks in the past few months that did a RS and traded much better after.


So if CUBT can RS onto the nasdaq with funding and a plan to monetize their drug port? Could be a huge winner. And I say that as a realist....not a Kool aid drinker.

[Student of the Game]

You definitely shouldn't be a shareholder with your training as a Student of the Game.

[moczowy]

Wish someone was a master of the game and give us good advice